Insider · CIK 0001943013
David Delaney
Files at KTTA (Pasithea Therapeutics Corp.). First filing Oct 19, 2022, latest Oct 19, 2022.
In brief
David Delaney files SEC Form 4 as insider at KTTA (Pasithea Therapeutics Corp.). Since Oct 19, 2022, David Delaney has reported 1 open-market buy worth $1,110 and 0 open-market sells worth $0, the latest filed on Oct 19, 2022.
A track record needs three past buys with six months of prices behind them; David Delaney has 0, so none is measured yet.
The newest scored trade: bought $1,110 of KTTA on Oct 17, 2022, filed Oct 19, 2022, scored 11 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KTTA: Pasithea Therapeutics Corp.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 11Weak | KTTAbuy Pasithea Therapeutics Corp. | $1,110 1,000 shares | +0% | +34% from low-80% from high |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 17, 2022 | KTTA Pasithea Therapeutics Corp. | POpen-market purchase Common Stockindirect: See footnote | +1,000 | $1.11 | $1,110 | 227,521 | Oct 19, 2022 |
Questions about David Delaney
Answered from the filings on this page, as of the latest one.
Is David Delaney buying or selling?
Not in the last 12 months. David Delaney's latest open-market trade on SEC Form 4 was bought $1,110 of KTTA on Oct 17, 2022.
How did David Delaney's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Delaney has 0.
Where does David Delaney file Form 4?
David Delaney has filed Form 4 at KTTA (Pasithea Therapeutics Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.